Pingping Xu
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
- Colorectal Cancer Surgical Treatments
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Papers in
-
- Sphingolipid Metabolism and Signaling 2
- Oncology 11
- Colorectal Cancer Surgical Treatments 5
- Cancer Cells and Metastasis 2
- Colorectal Cancer Treatments and Studies 2
- Co-authors
- Dexiang Zhu (14 shared papers)Ye Wei (13 shared papers)Qi Lin (12 shared papers)Jianmin Xu (12 shared papers)Li Ren (8 shared papers)Qingyang Feng (6 shared papers)Young C. Lin (9 shared papers)Meiling Ji (9 shared papers)
- Journals
- OncoTargets and Therapy (3 papers)Oncotarget (2 papers)PLoS ONE (2 papers)Pharmaceutical Research (1 paper)Journal of Applied Ecology (1 paper)
- Partner nations
- ChinaUnited StatesFinland
In The Last Decade
Pingping Xu
50 papers receiving 655 citations
Peers
Comparison fields: 5 of 80
- Oncology 220
- Cancer Research 121
- Hepatology 54
- Immunology 90
- Molecular Biology 217
Countries citing papers authored by Pingping Xu
This map shows the geographic impact of Pingping Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pingping Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pingping Xu more than expected).
Fields of papers citing papers by Pingping Xu
This network shows the impact of papers produced by Pingping Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pingping Xu. The network helps show where Pingping Xu may publish in the future.
Co-authors
The 25 scholars most cited alongside Pingping Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 51 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 58 | |
| 2 | 2015 | 50 | |
| 3 | 2022 | 47 | |
| 4 | 2018 | 42 | |
| 5 | 2014 | 34 | |
| 6 | 2016 | 34 | |
| 7 | 2015 | 32 | |
| 8 | 2018 | 26 | |
| 9 | (-)-Gossypol-enriched cottonseed oil inhibits proliferation and adipogenesis of human breast pre-adipocytes. | 2013 | 24 |
| 10 | 2014 | 23 | |
| 11 | Mitogenic activity of zeranol in human breast cancer cells is enhanced by leptin and suppressed by gossypol. | 2009 | 20 |
| 12 | 2020 | 20 | |
| 13 | 2016 | 18 | |
| 14 | 2011 | 18 | |
| 15 | 2015 | 16 | |
| 16 | Aromatase expression in leptin-pretreated human breast pre-adipocytes is enhanced by zeranol and suppressed by (-)-gossypol. | 2010 | 15 |
| 17 | 2019 | 15 | |
| 18 | Zeranol enhances the proliferation of pre-adipocytes in beef heifers. | 2009 | 15 |
| 19 | 2017 | 13 | |
| 20 | 2014 | 13 |
About Pingping Xu
Pingping Xu is a scholar working on Molecular Biology, Oncology, Epidemiology, Genetics and Plant Science, having authored 51 papers that have together received 659 indexed citations. Recurring topics across this work include Colorectal Cancer Surgical Treatments (5 papers), Hepatocellular Carcinoma Treatment and Prognosis (3 papers), Inflammatory Bowel Disease (3 papers), Research in Cotton Cultivation (3 papers), Hepatitis B Virus Studies (2 papers), Cancer Cells and Metastasis (2 papers), Colorectal Cancer Treatments and Studies (2 papers) and Sphingolipid Metabolism and Signaling (2 papers). The work is most often cited by research in Oncology (220 citations), Cancer Research (121 citations), Hepatology (54 citations), Immunology (90 citations) and Molecular Biology (217 citations). Pingping Xu has collaborated with scholars based in China, United States and Finland. Frequent co-authors include Dexiang Zhu, Ye Wei, Qi Lin, Jianmin Xu, Li Ren, Qingyang Feng, Young C. Lin, Meiling Ji, Shu‐Hong Lin and Zhengchuan Niu. Their work appears in journals such as OncoTargets and Therapy, Oncotarget, PLoS ONE, Pharmaceutical Research and Journal of Applied Ecology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.